Overhauling the breast cancer overview: are subsets subversive?

被引：12

作者：

Coates, AS

Goldhirsch, A

Gelber, RD

机构：

[1] Canc Council Australia, Sydney, NSW 2001, Australia

[2] European Inst Oncol, Milan, Italy

[3] Oncol Inst So Switzerland, Lugano, Switzerland

[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA

[5] Harvard Univ, Sch Med, Boston, MA 02115 USA

[6] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

LANCET ONCOLOGY | 2002年 / 3卷 / 09期

关键词：

D O I：

10.1016/S1470-2045(02)00842-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：525 / 526

页数：2

共 6 条

[1]

Abe O, 1998, LANCET, V352, P930

[2]

Clarke M, 1998, LANCET, V351, P1451

[3]

Subsets within the chemotherapy overview [J].

Coates, AS ;

Gelber, RD ;

Goldhirsch, A .

LANCET, 1998, 352 (9142) :1783-1784

[4]

Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis [J].

Cole, BF ;

Gelber, RD ;

Gelber, S ;

Coates, AS ;

Goldhirsch, A .

LANCET, 2001, 358 (9278) :277-286

[5]

Goldhirsch A, 2002, JNCI-J NATL CANCER I, V94, P1054

[6]

SIMES RJ, 2001, MONOGR NATL CANC I, V30, P146

← 1 →